Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | HRH1 | P35367 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL234697 | 1.00 | MEN1 (0.69) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Bromide SCHEMBL2995963 | 0.98 | MEN1 (0.67) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Hydrochloric Acid SCHEMBL8752465 | 0.98 | MEN1 (0.67) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL2565442 | 0.89 | MEN1 (0.69) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL17416718 | 0.88 | MEN1 (0.67) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL3445036 | 0.88 | MEN1 (0.67) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL3445035 | 0.88 | MEN1 (0.67) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL10899938 | 0.86 | MEN1 (0.65) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| Phytic Acid SCHEMBL1360053 | 0.86 | MEN1 (0.52) | MEN1KMT2ACYP1A2HRH1CYP2C19 | |
| SCHEMBL1644173 | 0.85 | MEN1 (0.68) | MEN1KMT2ACYP1A2HRH1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113396332-B | Method for evaluating pregnancy progression and premature abortion for clinical intervention and use thereof | 斯坦福大学托管董事会 | 2025-02-11 | — | — | CN | claimed |
| CN-115395108-B | Preparation method and application of aqueous electrolyte containing quaternary ammonium salt type amphoteric ion additive | 中南大学 | 2024-09-10 | — | — | CN | claimed |
| CN-118225951-A | Marker group for major depressive disorder and screening method and application thereof | 上海大学 | 2024-06-21 | — | — | CN | claimed |
| CN-115395108-A | Preparation method and application of water-based electrolyte containing quaternary ammonium salt type zwitterion additive | 中南大学 | 2022-11-25 | — | — | CN | claimed |
| WO-2022140565-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES (US) | 2022-06-30 | — | — | WO | claimed |
| US-10912752-B2 | Methods and compositions for reducing ocular discomfort | BRIEN HOLDEN VISION INSTITUTE LIMITED (AU) | 2021-02-09 | — | — | US | claimed |
| US-20190167625-A1 | METHODS AND COMPOSITIONS FOR REDUCING OCULAR DISCOMFORT | BRIEN HOLDEN VISION INSTITUTE LIMITED (AU) | 2019-06-06 | — | — | US | claimed |
| US-10085960-B2 | Methods and compositions for reducing ocular discomfort | BRIEN HOLDEN VISION INSTITUTE (AU) | 2018-10-02 | — | — | US | claimed |
| EP-2124925-B1 | COMPOSITION USEFUL FOR THE TREATMENT OF TYPE 2 DIABETES | ALFASIGMA SPA (IT) | 2018-06-27 | — | — | EP | claimed |
| US-9114120-B2 | Therapeutical method for the treatment of the Leber optic neuropathy | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P.A. (IT) | 2015-08-25 | — | — | US | claimed |
| US-6482585-B2 | Storage and maintenance of blood products including red blood cells and platelets | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-11-19 | — | — | US | claimed |
| US-20020102529-A1 | Recovering and storing blood for use in transfusion; obtain blood, insert into solution tube, irradiate and recover blood cell products | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-08-01 | — | — | US | claimed |
| EP-1187530-A1 | IMPROVED STORAGE AND MAINTENANCE OF BLOOD PRODUCTS INCLUDING RED BLOOD CELLS AND PLATELETS | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2002-03-20 | — | — | EP | claimed |
| WO-2000074483-A1 | IMPROVED STORAGE AND MAINTENANCE OF BLOOD PRODUCTS INCLUDING RED BLOOD CELLS AND PLATELETS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2000-12-14 | — | — | WO | claimed |
| US-RE36331-E | Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1999-10-05 | — | — | US | claimed |
| US-5496821-A | Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1996-03-05 | — | — | US | claimed |
| EP-0376899-B1 | USE OF L-CARNITINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE THERAPEUTICAL TREATMENT OF PERIPHERAL NEUROPATHIES | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1993-08-04 | — | — | EP | claimed |
| US-5227518-A | L-CARNITINE DERIVATIVES AS THERAPEUTICAL AGENTS FOR TREATING MYOPATHIES AND NEURONAL DEGENERATION AND FOR INHIBITING PROTEOLYSIS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1993-07-13 | — | — | US | claimed |
| EP-0516594-A1 | L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-12-02 | — | — | EP | claimed |
| EP-0376899-A2 | Use of L-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1990-07-04 | — | — | EP | claimed |